Comparison of in vitro dialysis release methods of loperamide-encapsulated liposomal gel for topical drug delivery

Abstract

Background The purpose of this study was to determine the most appropriate dialysis equilibrium method to assess liposomal gel formulations containing hydrophobic drugs, to give the most accurate indication of drug release. Methods Loperamide hydrochloride-encapsulated liposomes, composed of L-α-phosphatidylcholine and cholesterol (molar ratio of 2:1), were prepared according to the method of dried lipid film hydration. The liposomes were incorporated into a carbopol gel (0.5%, weight/weight). The release of the drug from the nanoparticles was assessed using a number of variations of the dialysis technique, taking into account solubility parameters and formulation. Method 1 (below saturation point) and Method 2 (above saturation point) used a dilution method to evaluate how drug concentration and solubility affects the in vitro drug-release profile of loperamide hydrochloride, while Methods 3 (below saturation point) and 4 (above saturation point) evaluated how drug concentration and the gel base affect the release profile. Results In Method 1, the liposomes showed a rapid release of just over 60% in the first 3 hours and then a slower, sustained release to just over 70% at 24 hours. Method 2 showed a gradual, sustained release profile with the liposomes with 55% release at 24 hours. In Method 3, the liposomes showed a rapid burst release of 98% at 2 hours. In Method 4, the liposomal gel had a rapid release of 60% within 3 hours and then a more gradual, sustained release with 86% release at 24 hours. The free drug suspension in Methods 2 and 4 showed a limited release across the dialysis membrane, in comparison to Methods 1 and 3, which showed a complete release in a timely manner. Conclusion This study has demonstrated that the actual method used for equilibrium dialysis plays a significant role in determining the true characteristics of a topical nanoformulation, with Method 3 providing the most accurate indication of the release of a hydrophobic drug from a topical liposomal formulation.

Influence of Lipid Composition, pH, and Temperature on Physicochemical Properties of Liposomes with Curcumin as Model Drug

“…The in vitro release kinetics of curcumin from liposomes were investigated using the dialysis bag method 39 . A dialysis bag 12 kDa molecular weight cut-off, Sigma-Aldrich was used.…”

Chelators influenced synthesis of chitosan–carboxymethyl cellulose microparticles for controlled drug delivery

“…The drug release kinetics for microcarriers was studied using dialysis membrane technique (Hua 2014) which is as follows: 10 mg samples of (CS-CMC-B1, CS-CMC-B2, CS-CMC-B3, CS-CUR-CMC-S1, CS-CUR-CMC-S2 and CS-CUR-CMC-S3) were separately tied in six dialysis membranes (AV flat width-32.34 mm, AV diameter-21.5 mm, capacity approx-3.63 m cm -1 ). They were placed separately in 50 ml of phosphate buffer solution (pH 6.8) and left at room temperature.…”

Development of Nicotine Loaded Chitosan Nanoparticles for Lung Delivery

“…However, several challenges are involved in the physical separation with high energy separation techniques. Continued drug release occurs during the separation process (Hua, 2014).…”

“…The dialysis membrane is used to separate nanoparticles from the released/dissolved drugs, which diffuse through the membrane for quantification, so separating the nanoparticles from the solvent containing the drug to be analysed (Hua, 2014). Drug release from the nanoparticles through the dialysis bag depends on the solubility of the drug from the nanoparticles as well as the diffusion of the dissolved drug through the dialysis membrane, which gives an apparent delay of release of drug from the nanoparticles.…”

“…Incomplete release data is likely to be collected with absence of sink condition or high equilibration time (Heng, Cutler, Chan, Yun, & Raper, 2008). Also, dialysis technique is not suitable for drugs which bind to the dialysis membrane (Hua, 2014). The thickness and permeability of membrane is another rate limiting factor that controls the diffusion of the released drug from the nanoparticles.…”